References
- Varalda A, Coscia A, Di Nicola P, et al. Medication and breastfeeding. J Biol Regul Homeost Agents. 2012;26:1–4.
- Howard CR, Lawrence RA. Drugs and breastfeeding. Clin Perinatol. 1999;26:447–478. Ito S, Lee A. Drug excretion into breast milk-Overview. Adv Drug Deliv Rev 2003;55:617–627.
- Lewellyn A, Stowe ZN. Psychotropic medications in lactation. J Clin Psych. 1998;59:41–52.
- Yoshida K, Smith B, Craggs M, et al. Neuroleptic drugs in breast-milk: a study of pharmacokinetics and of possible adverse effects in breast-fed infants. Psychol Med. 1998;28:81–91.
- Pirsaheb M, Limoee M, Namdari F, et al. Organochlorine pesticides residue in breast milk: a systematic review. Med J Islam Rep Iran. 2015;29:228.
- WHO. Fourth WHO-Coordinated Survey of Human Milk for Persistent Organic Pollutants; 2007. Available from: http://www.who.int/foodsafety/chem/POPprotocol.pdf.
- Nickerson K. Environmental contaminants in breast milk. J Midwifery Women’s Health. 2006;51:26–34.
- LaKind JS, Wilkins AA, Berlin CM. Environmental chemicals in human milk: a review of levels, infant exposures and health, and guidance for future research. Toxicol Appl Pharmacol. 2004;198:184–208.
- Fleishake JC. Models and methods for predicting drug transfer into human milk. Adv Drug Deliv Rev. 2003;55:643–652.
- Ito S, Lee A. Drug excretion into breast milk–overview. Adv Drug Deliv Rev. 2003;55:617–627.
- Giaginis C, Theocharis S, Tsantili-Kakoulidou A. Current toxicological aspects on drug and chemical transport and metabolism across the human placental barrier. Expert Opin Drug Metab Toxicol. 2012;18:1263–1275.
- Giaginis C, Tsantili-Kakoulidou A. Alternative measures of lipophilicity: from octanol-water partitioning to IAM retention. J Pharm Sci. 2008;97:2984–3004.
- Giaginis C, Tsantili-Kakoulidou A, Theocharis S. Assessing drug transport across the human placental barrier: from in vivo and in vitro measurements to the ex vivo perfusion method and in silico techniques. Curr Pharm Biotechnol. 2011;12:804–813.
- Giaginis C, Zira A, Theocharis S, et al. Application of quantitative structure-activity relationships for modeling drug and chemical transport across the human placenta barrier: a multivariate data analysis approach. J Appl Toxicol. 2009;29:724–733.
- Ito N, Ito K, Ikebuchi Y, et al. Organic cation transporter/solute carrier family 22a is involved in drug transfer into milk in mice. J Pharm Sci. 2014;103:3342–3348.
- Meyer Zu Schwabedissen HE, Kroemer HK. In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ABCG2). Handb Exp Pharmacol. 2011;201:325–371.
- Egido E, Müller R, Li-Blatter X, et al. Predicting activators and inhibitors of the breast cancer resistance protein (ABCG2) and P-Glycoprotein (ABCB1) based on mechanistic considerations. Mol Pharm. 2015;12:4026–4037.
- Xu Y, Egido E, Li-Blatter X, et al. Allocrite sensing and binding by the breast cancer resistance protein (ABCG2) and P-Glycoprotein (ABCB1). Biochemistry. 2015;54:6195–6206.
- Malone K, Papagni K, Ramini S, et al. Antidepressants, antipsychotics, benzodiazepines, and the breastfeeding dyad. Persp Psych Care. 2004;40:73–85.
- Giaginis C, Theocharis S, Tsantili-Kakoulidou A. Quantitative structure-activity relationships for PPAR-gamma binding and gene transactivation of tyrosine-based agonists using multivariate statistics. Chem Biol Drug Des. 2008;72:257–264.
- Chaves RG, Lamounier JA. Breastfeeding and maternal medication. J Pediatr (Rio J). 2004;80:S189–98.
- Hale TW. Drug therapy and breastfeeding: pharmacokinetics, risk factors, and effects on milk production. Neoreviews. 2004;5:e164.
- Kar S, Roy K. Prediction of milk/plasma concentration ratios of drugs and environmental pollutants using in silico tools: classification and regression based QSARs and pharmacophore mapping. Mol Inform. 2013;32:693–705.
- Agatonovic-Kustrin S, Ling LH, Tham SY, et al. Molecular descriptors that influence the amount of drugs transfer into human breast milk. J Pharm Biomed Anal. 2002;29:103–119.
- Fatemi MH, Ghorbanzad’e M. Classification of drugs according to their milk/plasma concentration ratio. Eur J Med Chem. 2010;45:5051–5055.
- Abraham MH, Gil-Lostes J, Fatemi M. Prediction of milk/plasma concentration ratios of drugs and environmental pollutants. Eur J Med Chem. 2009;44:2452–2458.
- Agatanovic-Kurstin S, Morton DW, Celebic D. QSAR: an in silico approach for predicting the partitioning of pesticides into breast milk. Combin Chem High Throughput Screen. 2013;16:223–232.
- Ito N, Ito K, Ikebuchi Y, et al. Prediction of drug transfer into milk considering Breast Cancer Resistance Protein (BCRP)-mediated transport. Pharm Res. 2015;32:2527–2537.
- Begg EJ, Duffull SB, Hackett LP, et al. Studying drugs in human milk: time to unify the approach. J Hum Lact. 2002;18:323–332.
- LaKind JS, Birnbach N, Borgert CJ, et al. Human milk surveillance and research of environmental chemicals: concepts for consideration in interpreting and presenting study results. J Toxicol Environ Health. 2002;65:1909–1928.
- Lawrence RA, Lawrence RM. Breastfeeding: a guide for the medical profession. 5th ed. St. Louis (MO): Mosby; 1999.